A list of innovations by the HPC Centres of Excellence, as spotted by the EU innovation radar
The use case assesses the impact of certain COVID-19 drugs on a human heart population
CompBioMed: CT2S – Digital twin application for patient treatment & Bone Strength: <em>In Silico</em> trials solution
One major goal of this use case is to develop an efficient digital twin solution for the estimation of long bone fracture risk in elderly patients.
The objectives of this use case were to demonstrate and assess the strong scaling performance of HemeLB to the largest core counts possible, and to demonstrate the ability of HemeLB to utilise this performance to study flows on human-scale vasculatures.
This article gives an overview over the various ways in which EU projects are using supercomputing applications to tackle and support the global challenge of containing the corona virus pandemic.
Scientists from VECMA and CompBioMed analyzed a model that predicts the spread of the corona virus by undertaking an extensive parametric sensitivity analysis and uncertainty quantification of the publicly available code.
The 2020 edition of the ETP4HPC Handbook of HPC projects is available, including – besides many other intiatives – introductions to all the 14 CoEs and FocusCoE.
Find out how the CoEs contribute to this year’s virtual Supercomputing Conference
CompBioMed, Centre of Excellence in computational bio medicine,
worked together with Janssen Pharmacentica NV to improve the
molecular simulations in drug discovery.